[HTML][HTML] A comprehensive review of integrative pharmacology-based investigation: A paradigm shift in traditional Chinese medicine
H Xu, Y Zhang, P Wang, J Zhang, H Chen… - … Pharmaceutica Sinica B, 2021 - Elsevier
… (PK–PD) correlations through the integration of knowledge from multiple disciplines and …
and discovery of potential new drugs, especially TCM-related combination drug discovery. …
and discovery of potential new drugs, especially TCM-related combination drug discovery. …
[HTML][HTML] Pharmacokinetics and pharmacodynamics of posaconazole
… to integrate the current knowledge on posaconazole pharmacokinetics, pharmacodynamics,
… therapeutic strategies in order to get a clear understanding of the clinical use of this drug. …
… therapeutic strategies in order to get a clear understanding of the clinical use of this drug. …
A critical and concise review of mass spectrometry applied to imaging in drug discovery
RJA Goodwin, Z Takats… - … Science of Drug Discovery, 2020 - journals.sagepub.com
… within drug discovery. We require new capabilities and strategies of integrated imaging to
… Integrated molecular imaging and advanced image analysis have the opportunity to provide …
… Integrated molecular imaging and advanced image analysis have the opportunity to provide …
Engineered tissues and strategies to overcome challenges in drug development
… While in vitro and non-human in vivo preclinical models have long been an integral
component in the history of drug development [4], they frequently fail to accurately predict a …
component in the history of drug development [4], they frequently fail to accurately predict a …
Evolution of the drug-target residence time model
RA Copeland - Expert Opinion on Drug Discovery, 2021 - Taylor & Francis
… with the pharmacokinetics of the drug. Hence, several attempts to integrate PK and residence
… Fisher laboratories have integrated compound PK rate constants with those for drug-target …
… Fisher laboratories have integrated compound PK rate constants with those for drug-target …
Digitally enabled, patient‐centric clinical trials: shifting the drug development paradigm
MF Dockendorf, BJ Hansen… - Clinical and …, 2021 - Wiley Online Library
… setting (patient‐centric sampling), (iii) use of digital devices to collect and measure
physiological and behavioral data (digital biomarkers), and (iv) use of data platforms that integrate …
physiological and behavioral data (digital biomarkers), and (iv) use of data platforms that integrate …
[HTML][HTML] Accelerated repurposing and drug development of pulmonary hypertension therapies for COVID-19 treatment using an AI-integrated biosimulation platform
… To that end, we developed an in silico modeling approach in repurposing of CCBs and
ACEi compounds, using an AI-integrated mechanistic modeling platform by utilizing known …
ACEi compounds, using an AI-integrated mechanistic modeling platform by utilizing known …
[HTML][HTML] … : current landscape of integrating QSP and machine learning: an ISoP QSP SIG white paper by the working group on the integration of quantitative systems …
… and begin realizing new opportunities in QSP and ML integration. The working group, which
… drug development decision making. The working group also concluded that the integration …
… drug development decision making. The working group also concluded that the integration …
ADMET profiling in drug discovery and development: perspectives of in silico, in vitro and integrated approaches
… various in silico ADMET tools in drug discovery and development process, and provides a
brief … of in silico tools and possible scope of integration with in vitro methods for enhancing the …
brief … of in silico tools and possible scope of integration with in vitro methods for enhancing the …
[HTML][HTML] A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery
… natural source for drug discovery regarding COVID-19 … medicines have been reviewed and
considered promising prophylactic agents, treatments, or lead compounds for drug discovery …
considered promising prophylactic agents, treatments, or lead compounds for drug discovery …